SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12095384
Source:
http://linkedlifedata.com/resource/pubmed/id/12095384
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019196
,
umls-concept:C0019693
,
umls-concept:C0449258
pubmed:issue
2
pubmed:dateCreated
2002-7-3
pubmed:abstractText
Conflicting reports exist regarding the effect of hepatitis C virus (HCV) on the progression of human immunodeficiency virus (HIV) disease.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/K24 AI-01637
,
http://linkedlifedata.com/resource/pubmed/grant/K24 DA-00342
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DA-11602
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DA-13806
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12095384-12095390
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antibodies
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0098-7484
pubmed:author
pubmed-author:ChaissonRichard ERE
,
pubmed-author:MehtaShruti HSH
,
pubmed-author:MooreRichard DRD
,
pubmed-author:SulkowskiMark SMS
,
pubmed-author:ThomasDavid LDL
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
288
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
199-206
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:12095384-Adult
,
pubmed-meshheading:12095384-Anti-HIV Agents
,
pubmed-meshheading:12095384-Antiretroviral Therapy, Highly Active
,
pubmed-meshheading:12095384-CD4 Lymphocyte Count
,
pubmed-meshheading:12095384-Cohort Studies
,
pubmed-meshheading:12095384-Disease Progression
,
pubmed-meshheading:12095384-Female
,
pubmed-meshheading:12095384-HIV Infections
,
pubmed-meshheading:12095384-Hepatitis C
,
pubmed-meshheading:12095384-Hepatitis C Antibodies
,
pubmed-meshheading:12095384-Humans
,
pubmed-meshheading:12095384-Male
,
pubmed-meshheading:12095384-Middle Aged
,
pubmed-meshheading:12095384-Proportional Hazards Models
,
pubmed-meshheading:12095384-Survival Analysis
,
pubmed-meshheading:12095384-Viral Load
pubmed:year
2002
pubmed:articleTitle
Hepatitis C and progression of HIV disease.
pubmed:affiliation
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St, Room 448, Baltimore, MD 21287-0003, USA. msulkows@jhmi.edu
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.